Macrophages in synovial inflammation

Frontiers in Immunology

Volumn 2, Issue OCT, 2011, Pages

  Kennedy, Aisling ^a   Fearon, Ursula ^a,b   Veale, Douglas J ^a,b   Godson, Catherine ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Arthritis; Inflammation; Macrophage

Indexed keywords

EID: 84867963850     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2011.00052     Document Type: Review

References (123)

1. Abdollahi-Roodsaz, S., Joosten, L. A. B., Koenders, M. I., Devesa, I., Roelofs, M. F., Radstake, T. R. D. J., Heuvelmans-Jacobs, M., Akira, S., Nicklin, M. J. H., Ribeiro-Dias, F. T., and Van Den Berg, W. B. (2008). Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis. J. Clin. Invest. 118, 205-216.
2. Abeles, A., and Pillinger, M. (2006). The role of the synovial fibroblast in rheumatoid arthritis: cartilage destruction and the regulation of matrix metalloproteinases. Bull. NYU. Hosp. Jt. Dis. 24, 20-24.
3. Alvaro-Gracia, J. M., Zvaifler, N. J., and Firestein, G. S. (1990). Cytokines in chronic inflammatory arthritis. V. Mutual antagonism between interferon-gamma and tumor necrosis factor-alpha on HLA-DR expression, proliferation, collagenase production, and granulocyte macrophage colonystimulating factor production by rheumatoid arthritis synoviocytes. J. Clin. Invest. 86, 1790-1798.
4. Andrén, M., Xiang, Z., Nilsson, G., and Kleinau, S. (2006). FcγRIIIexpressing macrophages are essential for development of collagen-induced arthritis. Scand. J. Immunol. 63, 282-289.
5. Arur, S., Uche, U. E., Rezaul, K., Fong, M., Scranton, V., Cowan, A. E., Mohler, W., and Han, D. K. (2003). Annexin I is an endogenous ligand that mediates apoptotic cell engulfment. Dev. Cell 4, 587-598.
6. Athanasou, N., Quinn, J., Heryet, A., Puddle, B., Woods, C., and Mcgee, J. (1988). The immunohistology of synovial lining cells in normal and inflamed synovium. J. Pathol. 155, 133-142.
7. Bertolini, D. R., Nedwin, G. E., Bringman, T. S., Smith, D. D., and Mundy, G. R. (1986). Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature 319, 516-518.
8. Biswas, S. K., Gangi, L., Paul, S., Schioppa, T., Saccani, A., Sironi, M., Bottazzi, B., Doni, A., Vincenzo, B., Pasqualini, F., Vago, L., Nebuloni, M., Mantovani, A., and Sica, A. (2006). A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kB and enhanced IRF-3/STAT1 activation). Blood 107, 2112-2122.
9. Bohuslav, J., Kravchenko, V. V., Parry, G. C., Erlich, J. H., Gerondakis, S., Mackman, N., and Ulevitch, R. J. (1998). Regulation of an essential innate immune response by the p50 subunit of NF-kappaB. J. Clin. Invest. 102, 1645-1652.
10. Bondeson, J., Blom, A. B., Wainwright, S., Hughes, C., Caterson, B., and Van Den Berg, W. B. (2010). The role of synovial macrophages and macrophage-produced mediators in driving inflammatory and destructive responses in osteoarthritis. Arthritis Rheum. 62, 647-657.
11. Bonnelye, E., Laurin, N., Jurdic, P., Hart, D. A., and Aubin, J. E. (2008). Estrogen receptor-related receptoralpha (ERR-alpha) is dysregulated in inflammatory arthritis. Rheumatology 47, 1785-1791.
12. Bresnihan, B., Pontifex, E., Thurlings, R. M., Vinkenoog, M., El-Gabalawy, H., Fearon, U., Fitzgerald, O., Gerlag, D. M., Rooney, T., Van De Sande, M. G., Veale, D., Vos, K., and Tak, P.-P. (2009). Synovial tissue sublining CD68 expression is a biomarker of therapeutic response in rheumatoid arthritis clinical trials: consistency across centers. J. Rheumatol. 36, 1800-1802.
13. Burmester, G., Stuhlmuller, B., Keyszer, G., and Kinne, R. (1997). Mononuclear phagocytes and rheumatoid synovitis.Mastermind or workhorse in arthritis? Arthritis Rheum. 40, 5-18.
14. Butler, D. M., Maini, R. N., Feldmann, M., and Brennan, F. M. (1995). Modulation of proinflammatory cytokine release in rheumatoid synovial membrane cell cultures. Comparison of monoclonal anti TNF-alpha antibody with the interleukin-1 receptor antagonist. Eur. Cytokine Netw. 6, 225-230.
15. Canete, J. D., Celis, R., Hernandez, M. V., Pablos, J. L., and Sanmarti, R. (2010). Synovial immunopathological changes associated with successful abatacept therapy in a case of severe refractory psoriatic arthritis. Ann. Rheum. Dis. 69, 935-936.
16. Canete, J. D., Suarez, B., Hernandez, M. V., Sanmarti, R., Rego, I., Celis, R., Moll, C., Pinto, J. A., Blanco, F. J., and Lozano, F. (2009). Influence of variants of Fc-gamma receptors IIA and IIIA on the American college of rheumatology and European league against rheumatism responses to anti-tumour necrosis factor-alpha therapy in rheumatoid arthritis. Ann. Rheum. Dis. 68, 1547-1552.
17. Chan, M. M.-Y., and Moore, A. R. (2010). Resolution of inflammation in murine autoimmune arthritis is disrupted by cyclooxygenase-2 inhibition and restored by prostaglandin E2-mediated lipoxin A4 production. J. Immunol. 184, 6418-6426.
18. Cheng, N., He, R., Tian, J., Ye, P. P., and Ye, R. D. (2008). Cutting edge: TLR2 is a functional receptor for acutephase serum amyloid A. J. Immunol. 181, 22-26.
19. Connolly, M., Veale, D. J., and Fearon, U. (2011). Acute serum amyloid A regulates cytoskeletal rearrangement, cell matrix interactions and promotes cell migration in rheumatoid arthritis. Ann. Rheum. Dis. 70, 1296-1303.
20. Cooper, N. J. (2000). Economic burden of rheumatoid arthritis: a systematic review. Rheumatology 39, 28-33.
21. D'Acquisto, F., Merghani, A., Lecona, E., Rosignoli, G., Raza, K., Buckley, C. D., Flower, R. J., and Perretti, M. (2007). Annexin-1 modulates T-cell activation and differentiation. Blood 109, 1095-1102.
22. D'Acquisto, F., Paschalidis, N., Raza, K., Buckley, C. D., Flower, R. J., and Perretti, M. (2008). Glucocorticoid treatment inhibits annexin-1 expression in rheumatoid arthritis CD4+ T cells. Rheumatology 47, 636-639.
23. Danning, C. L., Illei, G. G., Hitchon, C., Greer, M. R., Boumpas, D. T., and Mcinnes, I. B. (2000). Macrophagederived cytokine and nuclear factor kappaB p65 expression in synovial membrane and skin of patients with psoriatic arthritis. Arthritis Rheum. 43, 1244-1256.
24. Dawidowicz, K., Allanore, Y., Guedj, M., Pierlot, C., Bombardieri, S., Balsa, A., Westhovens, R., Barrera, P., Alves, H., Teixeira, V. H., Petit-Teixeira, E., Van De Putte, L., Van Riel, P., Prum, B., Bardin, T., Meyer, O., Cornelis, F., Dieude, P., and Ecraf, F. (2011). The interferon regulatory factor 5 gene confers susceptibility to rheumatoid arthritis and influences its erosive phenotype. Ann. Rheum. Dis. 70, 117-121.
25. Dayer, J. M., Beutler, B., and Cerami, A. (1985). Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J. Exp. Med. 162, 2163-2168.
26. Decker, Y., Mcbean, G., and Godson, C. (2009). Lipoxin A4 inhibits IL-1binduced IL-8 and ICAM-1 expression in 1321N1 human astrocytoma cells. Am. J. Physiol. Cell Physiol. 296, C1420-C1427.
27. Desreumaux, P., Dubuquoy, L., Nutten, S., Peuchmaur, M., Englaro, W., Schoonjans, K., Derijard, B., Desvergne, B., Wahli, W., Chambon, P., Leibowitz, M. D., Colombel, J.-F. D. R., and Auwerx, J. (2001). Attenuation of colon inflammation through activators of the retinoid X receptor (Rxr)/peroxisome proliferator-activated receptor g (Pparg) heterodimer. J. Exp. Med. 193, 827-838.
28. Dideberg, V., Kristjansdottir, G., Milani, L., Libioulle, C., Sigurdsson, S., Louis, E., Wiman, A.-C., Vermeire, S., Rutgeerts, P., Belaiche, J., Franchimont, D., Van Gossum, A., Bours, V., and Syvanen, A.-C. (2007).An insertion/ deletion polymorphism in the interferon regulatory factor 5 (IRF5) gene confers risk of inflammatory bowel diseases.Hum.Mol. Genet. 16, 3008-3016.
29. Dieguez-Gonzalez, R., Calaza, M., Perez-Pampin, E., De La Serna, A. R., Fernandez-Gutierrez, B., Castañeda, S., Largo, R., Joven, B., Narvaez, J., Navarro, F., Marenco, J. L., Vicario, J. L., Blanco, F. J., Fernandez-Lopez, J. C., Caliz, R., Collado-Escobar, M. D., Carreño, L., Lopez-Longo, J., Cañete, J. D., Gomez-Reino, J. J., and Gonzalez, A. (2008). Association of interferon regulatory factor 5 haplotypes, similar to that found in systemic lupus erythematosus, in a large subgroup of patients with rheumatoid arthritis. Arthritis Rheum. 58, 1264-1274.
30. Elliott, M. J., Maini, R. N., Feldmann, M., Long-Fox, A., Charles, P., Katsikis, P., Brennan, F. M., Walker, J., Bijl, H., Ghrayeb, J., and Woody, J. N. (1993). Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α. Arthritis Rheum. 36, 1681-1690.
31. Erwig, L.-P., Kluth, D. C., Walsh, G. M., and Rees, A. J. (1998). Initial cytokine exposure determines function of macrophages and renders them unresponsive to other cytokines. J. Immunol. 161, 1983-1988.
32. Ferlazzo, V., D'agostino, P., Milano, S., Caruso, R., Feo, S., Cillari, E., and Parente, L. (2003). Antiinflammatory effects of annexin-1: stimulation of IL-10 release and inhibition of nitric oxide synthesis. Int. Immunopharmacol. 3, 1363-1369.
33. Filep, J. N. G., Zouki, C., Petasis, N. A., Hachicha, M., and Serhan, C. N. (1999). Anti-inflammatory actions of lipoxin A4 stable analogs are demonstrable in human whole blood: modulation of leukocyte adhesion molecules and inhibition of neutrophilendothelial interactions. Blood 94, 4132-4142.
34. Fiore, S., Maddox, J. F., Perez, H. D., and Serhan, C. N. (1994). Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor. J. Exp. Med. 180, 253-260.
35. Firestein, G. S. (2003). Evolving concepts of rheumatoid arthritis. Nature 423, 356-361.
36. Firestein, G. S., and Zvaifler, N. J. (1990). How important are T cells in chronic rheumatoid synovitis? Arthritis Rheum. 33, 768-773.
37. Flower, R. J. (1988). Eleventh Gaddum memorial lecture. Lipocortin and the mechanism of action of the glucocorticoids. Br. J. Pharmacol. 94, 987-1015.
38. Franklin, E. C., Holman, H. R., Muller-Eberhard, H. J., and Kunkel, H. G. (1957). An unusual protein component of high molecular weight in the serum of certain patients with rheumatoid arthritis. J. Exp. Med. 105, 425-438.
39. Gladman, D. D. (2009). Psoriatic arthritis. Dermatol. Ther. 22, 40-55.
40. Godson, C., Mitchell, S., Harvey, K., Petasis, N. A., Hogg, N., and Brady, H. R. (2000). Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocytederived macrophages. J. Immunol. 164, 1663-1667.
41. Goedkoop, A. Y., Kraan, M. C., Teunissen, M. B. M., Picavet, D. I., De Rie, M. A., Bos, J. D., and Tak, P. P. (2004). Early effects of tumour necrosis factor {alpha} blockade on skin and synovial tissue in patients with active psoriasis and psoriatic arthritis. Ann. Rheum. Dis. 63, 769-773.
42. Goulding, N. J., Dixey, J., Morand, E. F., Dodds, R. A., Wilkinson, L. S., Pitsillides, A. A., and Edwards, J. C. (1995). Differential distribution of annexins-I, -II, -IV, and -VI in synovium. Ann. Rheum. Dis. 54, 841-845.
43. Goulding, N. J., Jefferiss, C. M., Pan, L., Rigby, W. F., andGuyre, P. M. (1992). Specific binding of lipocortin-1 (annexin I) to monocytes and neutrophils is decreased in rheumatoid arthritis. Arthritis Rheum. 35, 1395-1397.
44. Grabiec, A. M., Krausz, S., De Jager, W., Burakowski, T., Groot, D., Sanders, M. E., Prakken, B. J., Maslinski, W., Eldering, E., Tak, P. P., andReedquist, K. A. (2010). Histone deacetylase inhibitors suppress inflammatory activation of rheumatoid arthritis patient synovial macrophages and tissue. J. Immunol. 184, 2718-2728.
45. Grabiec, A. M., Tak, P. P., and Reedquist, K. A. (2008). Targeting histone deacetylase activity in rheumatoid arthritis and asthma as prototypes of inflammatory disease: should we keep our HATs on? Arthritis Res. Ther. 10, 226.
46. Graham, R. R., Kyogoku, C., Sigurdsson, S., Vlasova, I. A., Davies, L. R. L., Baechler, E. C., Plenge, R. M., Koeuth, T., Ortmann, W. A., Hom, G., Bauer, J. W., Gillett, C., Burtt, N., Cunninghame Graham, D. S., Onofrio, R., Petri, M., Gunnarsson, I., Svenungsson, E., Ronnblom, L., Nordmark, G., Gregersen, P. K., Moser, K., Gaffney, P. M., Criswell, L. A., Vyse, T. J., Syvanen, A.-C., Bohjanen, P. R., Daly, M. J., Behrens, T.W., and Altshuler, D. (2007). Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proc.Natl.Acad. Sci. 104, 6758-6763.
47. Han, S. W., Lee, W. K., Kwon, K. T., Lee, B. K., Nam, E. J., and Kim, G. W. (2009). Association of polymorphisms in interferon regulatory factor 5 gene with rheumatoid arthritis: a metaanalysis. J. Rheumatol. 36, 693-697.
48. Han, Z., Boyle, D. L., Manning, A. M., and Firestein, G. S. (1998). AP-1 and NF-kB regulation in rheumatoid arthritis and murine collageninduced arthritis. Autoimmunity 28, 197-208.
49. Handel, M. L., Mcmorrow, L. B., and Gravallese, E. M. (1995). Nuclear factor-kB in rheumatoid synovium. Localization of P50 and P65. Arthritis Rheum. 38, 1762-1770.
50. Haringman, J. J., Gerlag, D. M., Zwinderman, A. H., Smeets, T. J. M., Kraan, M. C., Baeten, D., Mcinnes, I. B., Bresnihan, B., and Tak, P. P. (2005). Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis. Ann. Rheum. Dis. 64, 834-838.
51. Heo, Y.-J., Joo, Y.-B., Oh, H.-J., Park, M.-K., Heo, Y.-M., Cho, M.-L., Kwok, S.-K., Ju, J.-H., Park, K.-S., Cho, S. G., Park, S.-H., Kim, H.-Y., and Min, J.-K. (2010). IL-10 suppresses Th17 cells and promotes regulatory T cells in the CD4+ T cell population of rheumatoid arthritis patients. Immunol. Lett. 127, 150-156.
52. Hong, C., Walczak, R., Dhamko, H., Bradley, M. N., Marathe, C., Boyadjian, R., Salazar, J. V., and Tontonoz, P. (2011). Constitutive activation of LXR in macrophages regulates metabolic and inflammatory gene expression: identification of ARL7 as a direct target. J. Lipid Res. 52, 531-539.
53. Huang, Q., Ma, Y., Adebayo, A., and Pope, R. M. (2007). Increased macrophage activation mediated through toll-like receptors in rheumatoid arthritis. Arthritis Rheum. 56, 2192-2201.
54. Huber, L. C., Brock, M., Hemmatazad, H., Giger, O. T., Moritz, F., Trenkmann, M., Distler, J. H. W., Gay, R. E., Kolling, C., Moch, H., Michel, B. A., Gay, S., Distler, O., and Jüngel, A. (2007). Histone deacetylase/acetylase activity in total synovial tissue derived from rheumatoid arthritis and osteoarthritis patients. Arthritis Rheum. 56, 1087-1093.
55. Janusz, M., and Hare, M. (1993). Cartilage degradation by cocultures of transformed macrophage and fibroblast cell lines. A model of metalloproteinase-mediated connective tissue degradation. J. Immunol. 150, 1922-1931.
56. Ji, J.-D., Tassiulas, I., Park-Min, K.-H., Aydin, A., Mecklenbrauker, I., Tarakhovsky, A., Pricop, L., Salmon, J. E., and Ivashkiv, L. B. (2003). Inhibition of interleukin 10 signaling after Fc receptor ligation and during rheumatoid arthritis. J. Exp. Med. 197, 1573-1583.
57. Joosten, L. A. B., Koenders, M. I., Smeets, R. L., Heuvelmans-Jacobs, M., Helsen, M. M. A., Takeda, K., Akira, S., Lubberts, E., Van De Loo, F. A. J., and Van Den Berg, W. B. (2003). Toll-like receptor 2 pathway drives streptococcal cell wallinduced joint inflammation: critical role ofmyeloid differentiation factor 88. J. Immunol. 171, 6145-6153.
58. Keffer, J., Probert, L., Cazlaris, H., Georgopoulos, S., Kaslaris, E., Kioussis, D., and Kollias, G. (1991). Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J. 10, 4025-4031.
59. Kraan, M. C., Versendaal, H., Jonker, M., Bresnihan, B., Post, W. J., T Hart, B. A., Breedveld, F. C., and Tak, P. P. (1998). Asymptomatic synovitis precedes clinically manifest arthritis. Arthritis Rheum. 41, 1481-1488.
60. Krausgruber, T., Blazek, K., Smallie, T., Alzabin, S., Lockstone, H., Sahgal, N., Hussell, T., Feldmann, M., and Udalova, I. A. (2011). IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nat. Immunol. 12, 231-238.
61. Kronke, G., Katzenbeisser, J., Uderhardt, S., Zaiss, M. M., Scholtysek, C., Schabbauer, G., Zarbock, A., Koenders, M. I., Axmann, R., Zwerina, J., Baenckler, H. W., Van Den Berg, W., Voll, R. E., Kuhn, H., Joosten, L. A. B., and Schett, G. (2009). 12/15-Lipoxygenase counteracts inflammation and tissue damage in arthritis. J. Immunol. 183, 3383-3389.
62. Kruithof, E., Rycke, L.D., Vandooren, B., Keyser, F.D., Fitzgerald, O., Mcinnes, I., Tak, P. P., Bresnihan, B., Veys, E. M., Baeten, D., and OMERACT Special Interest Group on Synovial Analysis in Clinical Trials. (2006). Identification of synovial biomarkers of response to experimental treatment in early-phase clinical trials in spondylarthritis. Arthritis Rheum. 54, 1795-1804.
63. Laurent, L., Clavel, C., Lemaire, O., Anquetil, F., Cornillet, M., Zabraniecki, L., Nogueira, L., Fournie, B., Serre, G., and Sebbag, M. (2011). Fc-gamma receptor profile of monocytes and macrophages from rheumatoid arthritis patients and their response to immune complexes formed with autoantibodies to citrullinated proteins. Ann. Rheum. Dis. 70, 1052-1059.
64. Leibovich, S. J., Polverini, P. J., Shepard, H. M., Wiseman, D. M., Shively, V., and Nuseir, N. (1987).Macrophageinduced angiogenesis is mediated by tumour necrosis factor-[alpha]. Nature 329, 630-632.
65. Maderna, P., Yona, S., Perretti, M., and Godson, C. (2005). Modulation of phagocytosis of apoptotic neutrophils by supernatant from dexamethasone-treated macrophages and annexin-derived peptide Ac2-26. J. Immunol. 174, 3727-3733.
66. Mantovani, A., Sica, A., Sozzani, S., Allavena, P., Vecchi, A., and Locati, M. (2004). The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25, 677-686.
67. Marlor, C., Webb, D., Bombara, M., Greve, J., and Blue, M. (1992). Expression of vascular cell adhesion molecule-1 in fibroblast like synoviocytes after stimulation with tumor necrosis factor. Am. J. Pathol. 140, 1055-1060.
68. Martinez, F. O., Sica, A., Mantovani, A., and Locati, M. (2008). Macrophage activation and polarization. Front. Biosci. 13, 453-461.
69. Mauri, C., Gray, D., Mushtaq, N., and Londei, M. (2003). Prevention of arthritis by interleukin 10-producing B cells. J. Exp. Med. 197, 489-501.
70. McInnes, I. B., Leung, B. P., and Liew, F. Y. (2000). Cell-cell interactions in synovitis: interactions between T lymphocytes and synovial cells. Arthritis Res. 2, 374-378.
71. Miceli-Richard, C., Comets, E., Loiseau, P., Puechal, X., Hachulla, E., and Mariette, X. (2007). Association of an IRF5 gene functional polymorphism with Sjögren's syndrome. Arthritis Rheum. 56, 3989-3994.
72. Milman, N., Karsh, J., and Booth, R. A. (2010). Correlation of a multicytokine panel with clinical disease activity in patients with rheumatoid arthritis. Clin. Biochem. 43, 1309-1314.
73. Miltenburg, A. M. M., Van Laar, J. M., De Kniper, M. R., Daha, M. R., and Breedveld, F. C. (1992). T cells cloned from human rheumatoid synovial membrane functionally represent the Th1 subset. Scand. J. Immunol. 35, 603-610.
74. Morales-Lara, M., Conesa-Zamora, P., Garcia-Simon, M., Pedrero, F., Santaclara, V., Perez-Guillermo, M., and Soriano-Navarro, E. (2010). Association between the FCGR3A V158F polymorphism and the clinical response to infliximab in rheumatoid arthritis and spondyloarthritis patients. Scand. J. Rheumatol. 39, 518-520.
75. Morgan, A. W., Barrett, J. H., Griffiths, B., Subramanian, D., Robinson, J. I., Keyte, V. H., Ali, M., Jones, E. A., Old, R. W., Ponchel, F., Boylston, A. W., Situnayake, R. D., Markham, A. F., Emery, P., and Isaacs, J. D. (2006). Analysis of Fcgamma receptor haplotypes in rheumatoid arthritis: FCGR3A remains a major susceptibility gene at this locus, with an additional contribution from FCGR3B. Arthritis Res. Ther. 8, R5.
76. Mottonen, M., Isomaki, P., Saario, R., Toivanen, P., Punnonen, J., and Lassila, O. (1998). Interleukin-10 inhibits the capacity of synovial macrophages to function as antigenpresenting cells. Rheumatology 37, 1207-1214.
77. Mulherin, D., Fitzgerald, O., and Bresnihan, B. (1996). Synovial tissue macrophage populations and articular damage in rheumatoid arthritis. Arthritis Rheum. 39, 115-124.
78. Mullan, R. H., Bresnihan, B., Golden-Mason, L., Markham, T., O'hara, R., Fitzgerald, O., Veale, D. J., and Fearon, U. (2006). Acutephase serum amyloid A stimulation of angiogenesis, leukocyte recruitment, and matrix degradation in rheumatoid arthritis through anNFkappaB-dependent signal transduction pathway. Arthritis Rheum. 54, 105-114.
79. Murphy, E. P., Mcevoy, A., Conneely, O. M., Bresnihan, B., and Fitzgerald, O. (2001). Involvement of the nuclear orphan receptor NURR1 in the regulation of corticotropin-releasing hormone expression and actions in human inflammatory arthritis. Arthritis Rheum. 44, 782-793.
80. Murray, P. J., and Wynn, T. A. (2011). Obstacles and opportunities for understanding macrophage polarization. J. Leukoc. Biol. 89, 557-563.
81. Nasu, Y., Nishida, K., Miyazawa, S., Komiyama, T., Kadota, Y., Abe, N., Yoshida, A., Hirohata, S., Ohtsuka, A., and Ozaki, T. (2008). Trichostatin A, a histone deacetylase inhibitor, suppresses synovial inflammation and subsequent cartilage destruction in a collagen antibody-induced arthritis mouse model. Osteoarthr. Cartil. 16, 723-732.
82. Nawroth, P., Bank, I., Handley, D., Cassimeris, J., Chess, L., and Stern, D. (1986). Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1. J. Exp. Med. 163, 1363-1375.
83. O'Hara, R., Murphy, E. P., Whitehead, A. S., Fitzgerald, O., and Bresnihan, B. (2000). Acute-phase serum amyloid A production by rheumatoid arthritis synovial tissue.Arthritis Res. Ther. 2, 142-144.
84. Okamura, Y., Watari, M., Jerud, E. S., Young, D.W., Ishizaka, S. T., Rose, J., Chow, J. C., and Strauss, J. F. (2001). The extra domain A of fibronectin activates toll-like receptor 4. J. Biol. Chem. 276, 10229-10233.
85. Oosterveer, M. H., Grefhorst, A., Groen, A. K., and Kuipers, F. (2010). The liver X receptor: control of cellular lipid homeostasis and beyond: implications for drug design. Prog. Lipid Res. 49, 343-352.
86. Park, J. S., Svetkauskaite, D., He, Q., Kim, J.-Y., Strassheim, D., Ishizaka, A., and Abraham, E. (2004). Involvement of toll-like receptors 2 and 4 in cellular activation by highmobility group box 1 protein. J. Biol. Chem. 279, 7370-7377.
87. Park, M.-C., Kwon, Y.-J., Chung, S.-J., Park, Y.-B., and Lee, S.-K. (2010). Liver X receptor agonist prevents the evolution of collagen-induced arthritis in mice. Rheumatology 49, 882-890.
88. Pei, L., Castrillo, A., and Tontonoz, P. (2006). Regulation of macrophage inflammatory gene expression by the orphan nuclear receptorNur77.Mol. Endocrinol. 20, 786-794.
89. Perlman, H., Pagliari, L. J., Liu, H., Koch, A. E., Haines, G. K., and Pope, R. M. (2001). Rheumatoid arthritis synovial macrophages express the Fas-associated death domain-like interleukin-1β-converting enzyme-inhibitory protein and are refractory to Fas-mediated apoptosis. Arthritis Rheum. 44, 21-30.
90. Perretti, M., and Dalli, J. (2009). Exploiting the annexin A1 pathway for the development of novel antiinflammatory therapeutics. Br. J. Pharmacol. 158, 936-946.
91. Podgorski, M. R., Goulding, N. J., Hall, N. D., Flower, R. J., and Maddison, P. J. (1992). Autoantibodies to lipocortin-1 are associated with impaired glucocorticoid responsiveness in rheumatoid arthritis. J. Rheumatol. 19, 1668-1671.
92. Porta, C., Rimoldi, M., Raes, G., Brys, L., Ghezzi, P., Di Liberto, D., Dieli, F., Ghisletti, S., Natoli, G., De Baetselier, P., Mantovani, A., and Sica, A. (2009). Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kB. Proc. Natl. Acad. Sci. 106, 14978-14983.
93. Roiniotis, J., Dinh, H., Masendycz, P., Turner, A., Elsegood, C. L., Scholz, G. M., and Hamilton, J. A. (2009). Hypoxia prolongs monocyte/macrophage survival and enhanced glycolysis is associated with their maturation under aerobic conditions. J. Immunol. 182, 7974-7981.
94. Saccani, A., Schioppa, T., Porta, C., Biswas, S. K., Nebuloni, M., Vago, L., Bottazzi, B., Colombo, M. P., Mantovani, A., and Sica, A. (2006). p50 Nuclear factor-kB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance. Cancer Res. 66, 11432-11440.
95. Salmon, M., Scheel-Toellner, D., Huissoon, A. P., Pilling, D., Shamsadeen, N., Hyde, H., D'angeac, A.D., Bacon, P. A., Emery, P., and Akbar, A. N. (1997). Inhibition of T cell apoptosis in the rheumatoid synovium. J. Clin. Invest. 99, 439-446.
96. Sampey, A. V., Hutchinson, P., and Morand, E. F. (2000). Annexin I surface binding sites and their regulation on human fibroblast-like synoviocytes. Arthritis Rheum. 43, 2537-2542.
97. Satoh, T., Takeuchi, O., Vandenbon, A., Yasuda, K., Tanaka, Y., Kumagai, Y., Miyake, T., Matsushita, K., Okazaki, T., Saitoh, T., Honma, K., Matsuyama, T., Yui, K., Tsujimura, T., Standley, D. M., Nakanishi, K., Nakai, K., and Akira, S. (2010). The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nat. Immunol. 11, 936-944.
98. Scannell, M., Flanagan, M. B., Destefani, A., Wynne, K. J., Cagney, G., Godson, C., andMaderna, P. (2007). Annexin-1 and peptide derivatives are released by apoptotic cells and stimulate phagocytosis of apoptotic neutrophils by macrophages. J. Immunol. 178, 4595-4605.
99. Schulze-Koops, H., and Kalden, J. R. (2001). The balance of Th1/Th2 cytokines in rheumatoid arthritis. Best Pract. Res. Clin. Rheumatol. 15, 677-691.
100. Serhan, C. N., Hamberg, M., and Samuelsson, B. (1984). Lipoxins: novel series of biologically active compounds formed from arachidonic acid in human leukocytes. Proc. Natl. Acad. Sci. 81, 5335-5339.
101. Sodin-Semrl, S., Spagnolo, A., Mikus, R., Barbaro, B., Varga, J., and Fiore, S. (2004). Opposing regulation of interleukin-8 and NF-kappaB responses by lipoxin A4 and serum amyloid A via the common lipoxin A receptor. Int. J. Immunopathol. Pharmacol. 17, 145-156.
102. Ståhl, T. D. D., Andrén, M., Martinsson, P., Verbeek, J. S., and Kleinau, S. (2002). Expression of FcγRIII is required for development of collagen-induced arthritis. Eur. J. Immunol. 32, 2915-2922.
103. Stout, R. D., Jiang, C., Matta, B., Tietzel, I., Watkins, S. K., and Suttles, J. (2005). Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. J. Immunol. 175, 342-349.
104. Tagoe, C. E., Marjanovic, N., Park, J. Y., Chan, E. S., Abeles, A. M., Attur, M., Abramson, S. B., and Pillinger, M.H. (2008). Annexin-1 mediates TNF-a stimulated matrixmetalloproteinase secretion from rheumatoid arthritis synovial fibroblasts. J. Immunol. 181, 2813-2820.
105. Tak, P. P., Smeets, T. J. M., Daha, M. R., Kluin, P. M., Meijers, K. A. E., Brand, R., Meinders, A. E., and Breedveld, F. C. (1997). Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity. Arthritis Rheum. 40, 217-225.
106. Tamura, T., Tailor, P., Yamaoka, K., Kong, H. J., Tsujimura, H., Oâ'shea, J. J., Singh, H., and Ozato, K. (2005). IFN regulatory factor-4 and -8 govern dendritic cell subset development and their functional diversity. J. Immunol. 174, 2573-2581.
107. Thabet, M. M., Huizinga, T.W. J., Marques, R. B., Stoeken-Rijsbergen, G., Bakker, A. M., Kurreeman, F. A., White, S. J., Toes, R. E. M., and Van Der Helm-Van Mil, A. H. M. (2009). Contribution of Fcgamma receptor IIIA gene 158V/F polymorphism and copy number variation to the risk of ACPA-positive rheumatoid arthritis. Ann. Rheum. Dis. 68, 1775-1780.
108. Thomas, E., Leroux, J. L., Blotman, F., and Chavis, C. (1995). Conversion of endogenous arachidonic acid to 5, 15-diHETE and lipoxins by polymorphonuclear cells from patients with rheumatoid arthritis. Inflamm. Res. 44, 121-124.
109. Thurlings, R. M., Vos, K., Wijbrandts, C. A., Zwinderman, A. H., Gerlag, D. M., and Tak, P. P. (2008). Synovial tissue response to rituximab: mechanism of action and identification of biomarkers of response. Ann. Rheum. Dis. 67, 917-925.
110. Tsao, P. W., Suzuki, T., Totsuka, R., Murata, T., Takagi, T., Ohmachi, Y., Fujimura, H., and Takata, I. (1997). The effect of dexamethasone on the expression of activatedNF-[kappa]B in adjuvant arthritis. Clin. Immunol. Immunopathol. 83, 173-178.
111. Vallejo, A. N., Yang, H., Klimiuk, P. A., Weyand, C. M., and Goronzy, J. J. (2003). Synoviocyte-mediated expansion of inflammatory T cells in rheumatoid synovitis is dependent on CD47-thrombospondin 1 interaction. J. Immunol. 171, 1732-1740.
112. van Lent, P. L. E. M., Licht, R., Dijkman, H., Holthuysen, A. E. M., Berden, J. H. M., and Van Den Berg, W. B. (2001). Uptake of apoptotic leukocytes by synovial lining macrophages inhibitsimmune complex-mediated arthritis. J. Leukoc. Biol. 70, 708-714.
113. Vandooren, B., Noordenbos, T., Ambarus, C., Krausz, S., Cantaert, T., Yeremenko, N., Boumans, M., Lutter, R., Tak, P. P., and Baeten, D. (2009). Absence of a classically activated macrophage cytokine signature in peripheral spondylarthritis, including psoriatic arthritis. Arthritis Rheum. 60, 966-975.
114. Waaler, E. (1940). On the occurrence of a factor in human serum activating the specific agglutintion of sheep blood corpuscles. APMIS 115, 422-438.
115. Wahid, S., Blades, M. C., Lord, D. D., Brown, I., Blake, G., Yanni, G., Haskard, D. O., Panayi, G. S., and Pitzalis, C. (2000). Tumour necrosis factor-alpha (TNF-alpha) enhances lymphocyte migration into rheumatoid synovial tissue transplanted into severe combined immunodeficient (SCID) mice. Clin. Exp. Immunol. 122, 133-142.
116. Wakamatsu, K., Nanki, T., Miyasaka, N., Umezawa, K., and Kubota, T. (2005). Effect of a small molecule inhibitor of nuclear factor-κB nuclear translocation in amurine model of arthritis and cultured human synovial cells. Arthritis Res. Ther. 7, R1348-R1359.
117. Wallet, M. A., Wallet, S. M., Guiulfo, G., Sleasman, J. W., and Goodenow, M. M. (2010). IFN-gamma primes macrophages for inflammatory activation by high molecular weight hyaluronan. Cell. Immunol. 262, 84-88.
118. Walmsley, M., Katsikis, P. D., Abney, E., Parry, S., Williams, R. O., Maini, R. N., and Feldmann, M. (1996). Interleukin-10 inhibition of the progression of established collageninduced arthritis. Arthritis Rheum. 39, 495-503.
119. Whalen, J. D., Lechman, E. L., Carlos, C. A., Weiss, K., Kovesdi, I., Glorioso, J. C., Robbins, P.D., and Evans, C. H. (1999). Adenoviral transfer of the viral IL-10 Gene periarticularly to mouse paws suppresses development of collagen-induced arthritis in both injected and uninjected paws. J. Immunol. 162, 3625-3632.
120. Williams, R. O., Feldmann, M., and Maini, R. N. (1992). Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc. Natl. Acad. Sci. 89, 9784-9788.
121. Williams, S. L., Milne, I. R., Bagley, C. J., Gamble, J. R., Vadas, M. A., Pitson, S. M., and Khew-Goodall, Y. (2010). A proinflammatory role for proteolytically cleaved annexin A1 in neutrophil transendothelial migration. J. Immunol. 185, 3057-3063.
122. Yang, Y., Hutchinson, P., and Morand, E. F. (1999). Inhibitory effect of annexin I on synovial inflammation in rat adjuvant arthritis. Arthritis Rheum. 42, 1538-1544.
123. Yang, Y. H., Hutchinson, P., Santos, L. L., and Morand, E. F. (1998). Glucocorticoid inhibition of adjuvant arthritis synovial macrophage nitric oxide production: role of lipocortin 1. Clin. Exp. Immunol. 111, 117-122.